ArticleScientific reports2026
Exogenous benzyladenine reinforces the antioxidant activity, phytochemical content, and macronutrients of Tagetes erecta plants.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growth regulators have become an effective tool for enhancing the cultivation of medicinal and aromatic plants by promoting vegetative development and increasing the accumulation of bioactive metabolites. Benzyladenine (BA), a synthetic cytokinin, is widely recognized for its ability to influence growth and secondary metabolism in ornamental species; however, dose response evaluations under open field conditions remain limited for Tagetes erecta. This study examined the effects of foliar BA applications at 0, 50, 75, and 100 ppm, applied weekly over three intervals, on vegetative growth, pigment composition, antioxidant-related metabolites, and macronutrient status. BA treatments significantly improved all measured parameters relative to untreated plants, with responses showing a clear concentration dependent trend. The 100 ppm treatment produced the most pronounced enhancements, yielding maximum vegetative growth (72.133 cm height, 177.80 g fresh weight, 74.26 g dry weight), highest pigment levels (8.35 mg/100 g FW chlorophyll a, 5.88 mg/100 g FW chlorophyll b, 5.12 mg/100 g FW carotenoids), improved mineral content (3.15% nitrogen, 0.454% phosphorus, 2.92% potassium), and elevated antioxidant properties (25.844% antioxidant activity, 94.2 mg/100 g FW total phenols, 2.884 mg/100 g FW total flavonoids). These findings demonstrate that BA, particularly at 100 ppm, effectively enhances growth performance and secondary metabolite accumulation in T. erecta, providing field-based evidence for the role of cytokinins in optimizing the agronomic and phytochemical potential of this economically important ornamental species.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.